Episodes

President Biden outlines a new COVID-19 strategy, the U.S. Senate returns to Washington, and the House of Representatives debates prescription drug prices. Hosts Terry Wilcox and Dr. Bob Goldberg break down D.C.’s busy week and what chronic disease...

Want greater access to your doctor at a lower price? It’s possible through direct primary care. This healthcare solution allows patients to develop personal relationships with their doctors and receive care quicker and cheaper. Three physicians...

What can Congress do to aid in the fight against ovarian cancer? If reauthorized, Johanna’s Law would increase funding for ovarian cancer education and awareness programs.  Ovarian Cancer Research Alliance’s VP of Policy, Chad Ramsey,...

Kids across the country are headed back to school. But as the Delta variant spreads, what should families living with chronic disease know to stay healthy and safe? Pediatrician Dr. Marlene Wust-Smith gives a back-to-school c...

What’s the purpose of a patent? In the pharmaceutical industry, it helps manufacturers reinvest in new research and development to improve upon treatments and drugs. It’s a key part of the cycle of developing new treatments. ...

Premiums, deductibles, and copays continue to rise as insurance companies grow fat through mergers and monopolies. Host Terry Wilcox speaks with former insurance executive-turned-advocate Wendell Potter. Together, they explor...

The Delta variant, a breakdown of the FDA’s accelerated approval process, and how pink socks are bringing together patient advocacy groups. Hosts Dr. Bob Goldberg and guest host Kate Pecora dive into the news of the week, inc...

Opioid overdoses are rising as the COVID-19 pandemic continues. In 2020, overdose deaths rose by 30%. However, many chronic disease patients rely on prescription opioids for their healthcare regimen. We examine a balanced pol...

The high price tag for a new Alzheimer’s drug has fueled the ongoing drug price debate. But will patients really pay sticker price? (Spoiler alert: No!). Co-host Dr. Bob Goldberg explains the research/value assessment of the ...

Access to all of your health data - MRIs, screenings, and lab results - could be right at your fingertips. COVID-19 put healthcare tech companies into high gear to deliver health data to patients. The end result? Empowered pa...

Patients depend on safety and accuracy of medical equipment. If they’re improperly repaired, it could derail a patient’s healthcare journey and risk their health and safety. The Right to Repair Act aims to expedite medical de...

Doctor’s visits, tests, procedures and therapies are just one part of a healthcare journey. Knowing and understanding the laws that govern and protect your right to work, along with health insurance coverage and reimbursement...

Drama continues to unfold following the FDA’s controversial approval of a new Alzhiemer’s treatment. Members of the FDA’s advisory committee voted against approval, and some members resigned in protest. But how does this impa...

A new FDA-approved drug for Alzheimer’s signals a breakthrough in innovation for patients and caregivers, but has raised doubts from some over the price tag and approval process. Confused about what all of this means for you?...

Following a pandemic that exposed disparities, and failures to patients with chronic disease, now is the time for lawmakers and the industry in the U.S. to rethink its approach to healthcare. On this episode: how to create su...

Can you tell the difference between an advertising claim and research-backed statistics? For chronic disease patients who take supplements to manage their conditions, this is an ongoing problem. And the Food and Drug Administ...

More than 60 million Americans live with allergies or asthma. COVID-19 brought much needed attention to lung and respiratory challenges, but where do allergy and asthma patients go now in this emerging post-pandemic world? To...

Demands for mental and behavioral health services are on the rise. These services represented nearly half of all telehealth claims during the pandemic, but the digital divide and lack of in-network mental health providers cre...

When it comes to saving a buck, rare and chronic disease patients are too often put on the chopping block. Accelerated approval drugs are key to treating life threatening diseases. So why is Medicaid and CHIP Payment and Acce...

Patients rely on access to a broad range of innovative and effective medications to find a treatment option that best suits them. But restrictive formularies and price caps could prevent patients from accessing newer medicati...

April is Donate Life Month, and we examine many challenges facing organ transplant recipients. Amidst the physical and emotional toll of surgery, many patients also have to juggle apartment searching, moving, and financing a ...

The FDA’s Acting Commissioner Dr. Janet Woodcock brings listeners inside the FDA. While the agency’s hands are full with a global pandemic, the FDA is also still tasked with shepherding accelerated approvals for rare and chro...

The most effective treatments are often out of reach for patients. Big news came from the FDA announcing the approval of CAR-T therapies for multiple myeloma patients, but drug assessments from third-party groups are concerni...

You may have seen Johns Hopkins Hospital surgeon Dr. Marty Makary all over the national news this week, and he also joins the Patients Rising Podcast to talk with us about the winners and losers in the healthcare system, why ...